AI-guided prediction of ncRNA biochemical features for therapeutic targeting
Trends in Pharmacological Sciences · 2026-07 · 47 (7) · 743-759
DOI: 10.1016/j.tips.2026.05.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026-07. Verfasst von Jun Wei Chan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of NF-κB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 1386…. Hauptthemen laut MEDLINE: RNA, Untranslated, Artificial Intelligence. Die Arbeit nennt 120 Literaturangaben. Gefördert von: National Research Foundation, Agency for Science, Technology and Research, National Medical Research Council.
Abstract (Originalsprache)
Noncoding RNAs (ncRNAs) are increasingly recognized as important therapeutic targets across human diseases, driving advances in RNA-targeting modalities. However, successful therapeutic engagement depends on key biochemical properties of the target ncRNA, including subcellular localization, higher-order structure, and accessibility, which influence the suitability of different RNA-targeting modalities. Historically, resolving these properties relied on labor-intensive experimentation, limiting rational prioritization of RNA-targeting modalities. Emerging artificial intelligence (AI) tools can now predict ncRNA biochemical features at scale, enabling systematic characterization of target properties relevant to therapeutic design. In this opinion article, we outline AI approaches for predicting ncRNA localization, structure, and accessibility, including deep learning models, RNA structural predictors, and therapeutic prioritization frameworks. We discuss how these tools may support informed selection of RNA-targeting modalities, while highlighting current limitations and future opportunities for AI-guided therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of NF-κB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore; Department of Medicine, Yong Loo Lin School of Medicine…
- Laboratory of NF-κB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
- Programme in Translational and Clinical Liver Research, National Cancer Centre Singapore, Singapore, Singapore; Department of Hepatopancreatobiliary and Transplant Surgery, National Cancer Centre Singapore and Singapore…
- Centre for Computational Biology and Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore; Single-Cell Multi/Spatial-Omics and Precision Immunology, Bioinformatic…
- Laboratory of NF-κB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore; Department of Biochemistry, Yong Loo Lin School of Medi…
Förderung
- National Research Foundation
- Agency for Science, Technology and Research
- National Medical Research Council
Zitieren
APA
Chan, J. W., Daly, C. W. P., Vargas-Velazquez, A. M., Chow, P. K. H., Chen, J., & Tergaonkar, V. (2026). AI-guided prediction of ncRNA biochemical features for therapeutic targeting. Trends in Pharmacological Sciences, 47(7), 743-759. https://doi.org/10.1016/j.tips.2026.05.004
Vancouver
Chan JW, Daly CWP, Vargas-Velazquez AM, Chow PKH, Chen J, Tergaonkar V. AI-guided prediction of ncRNA biochemical features for therapeutic targeting. Trends in Pharmacological Sciences. 2026;47(7):743-759. doi:10.1016/j.tips.2026.05.004
BibTeX
@article{Chan2026,
author = {Chan, Jun Wei and Daly, Ciarán W P and Vargas-Velazquez, Amhed Missael and Chow, Pierce K H and Chen, Jinmiao and Tergaonkar, Vinay},
title = {AI-guided prediction of ncRNA biochemical features for therapeutic targeting},
journal = {Trends in Pharmacological Sciences},
year = {2026},
volume = {47},
number = {7},
pages = {743--759},
doi = {10.1016/j.tips.2026.05.004}
}
EUVIMED